Clearside Biomedical's CMO presented drug development insights at the Edridge Green Lecture, published in Eye journal, focusing on retinal disease trials. Clearside Biomedical, Inc., a ...
Each year, more than 55,000 Americans are diagnosed with pancreatic cancer. Despite being the one of the most heavily researched and well-understood cancers, it remains one of the most difficult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback